Microdialysis Technology Updates Data Access for Oncology Drug Development

Media Coverage
Image of vaccine vials.

Pharmaceutical Technology

A new addition to the Tumor Model Compendium provides access to an expanded collection of tumor models for early stage oncology research, noted Charles River Laboratories International, in a Nov. 13, 2018 press release.

The most recent update to the Compendium adds gastric and liver models as well as new molecular data for leukemia, liver cancer, lymphoma, breast cancer, and ovarian cancer. These additions provide oncology researchers access to data that allows identification of the most appropriate tumor models, which in turn can lead to a more targeted study design at the outset, reportedly saving time and money on the path to the clinic, according to Charles River.

Read the Full Article